Xanthogranulomatous cholecystitis expressing high levels of DUPAN-II

[1]  T. Tajiri,et al.  MIRIZZI SYNDROME CAUSED BY XANTHOGRANULOMATOUS CHOLECYSTITIS : REPORT OF A CASE , 2007 .

[2]  S. Yokoyama,et al.  CT and MR imaging findings of xanthogranulomatous cholecystitis: correlation with pathologic findings , 2004, European Radiology.

[3]  Tsuyoshi Enomoto,et al.  Xanthogranulomatous cholecystitis mimicking stage IV gallbladder cancer. , 2003, Hepato-gastroenterology.

[4]  H. Honda,et al.  Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. , 2002, AJR. American journal of roentgenology.

[5]  P. Ros,et al.  Xanthogranulomatous cholecystitis versus gallbladder carcinoma. , 1997, Radiology.

[6]  M. Lan,et al.  Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen. , 1987, The Journal of biological chemistry.

[7]  M. Borowitz,et al.  Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. , 1982, Cancer research.

[8]  K. Ishak,et al.  Xanthogranulomatous cholecystitis , 1981, The American journal of surgical pathology.

[9]  Ishak Kg,et al.  Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. , 1970 .

[10]  T. Kasai,et al.  Increased serum CA19-9 in patients with xanthogranulomatous cholecystitis. , 1998, Hepato-gastroenterology.

[11]  R. Adkins,et al.  Xanthogranulomatous cholecystitis. A clinical and pathologic study of twelve cases. , 1989, The American surgeon.

[12]  Dao Ah,et al.  Xanthogranulomatous cholecystitis. A clinical and pathologic study of twelve cases. , 1989 .